International Multiple Sclerosis Visual System Consortium
February 24, 2021
10:30am – 12:00pm PST/ 12:30pm-2:00pm CST / 1:30-3:00pm EST / 6:30-8:00pm GMT / 7:30-9:00pm GMT+1
Please join us for the IMSVISUAL Member Meeting, taking place on February 24, 2021. An agenda for the meeting will be circulated to all registrants once finalized.
If you would like to attend the IMSVISUAL Member Meeting, please register for the meeting and suggest any agenda items through this survey.
IMSVISUAL will hold a virtual symposium in conjunction with the ACTRIMS Forum 2021, which will take place virtually February 25-27, 2021. The IMSVISUAL Symposium is available to all registrants of the ACTRIMS Forum 2021
Symposium Chairs: E. Ann Yeh, The Hospital for Sick Children and Philipp Albrecht, University Hospital Düsseldorf
Six Months Results from the TONE Trial (Treatment of Optic Neuritis with Erythropoietin) in the Context of Visual Pathway Neuroprotection
Wolf Lagrèze, Universitätsklinikum Freiburg
Visual Outcome Metrics in MS: What are the Opportunities?
Heather Moss, Stanford University
Socioeconomic Disparity Correlates with Faster Inner Retinal Layer Thickness in Multiple Sclerosis
Elena Vasileiou, Johns Hopkins University School of Medicine
Identification of Optical Coherence Tomography Phenotypes and their Relationship with Patient Outcomes in Youth with Demyelinating Syndromes: Preliminary Results of an Unsupervised Machine Learning Analysis
Beyza Cifti-Kavakioglu, The Hospital for Sick Children
Neuroprotective Effects of the Sphingosine 1 Phosphate Receptor 1/5 Modulator RP-101074 on Retinal Neurodegeneration and Visual Function in Light-Induced Photoreceptor Loss
Christina Hecker, UKD
Thursday, February 27, 2020, 11:15 am – 1:45 pm
Palm Beach County Convention Center, Grand Ballroom
This symposium is included in your ACTRIMS Forum 2020 registration. You must be registered for the Forum to attend this symposium.
| Part 1: Chaired by Jiwon Oh, University of Toronto; Alex Brandt, Charité-Universitätsmedizin Berlin | |
| 11:15am-11:35am | Harmonizing Neuroimaging Data in Collaborative Networks Taki Shinohara, University of Pennsylvania |
| 11:35am-11:50am | Visual Outcomes in Pediatric Demyelinating Disorders Ann Yeh, The Hospital for Sick Children |
| 11:50am-12:05pm | Retinal Ganglion Cell Layer Thickness for Risk Stratification in Early Multiple Sclerosis Hanna Zimmermann, Charité-Universitätsmedizin Berlin |
| 12:05pm-12:15pm | A New MRI Method for Visualizing Subpial Cortical Lesions at 3 Tesla Erin Beck, National Institute of Neurological Disorders and Stroke, National Institutes of Health |
| 12:15pm-12:45pm | LUNCH |
| Part 2: Chaired by Shiv Saidha, Johns Hopkins University; Eric Klawiter, Massachusetts General Hospital | |
| 12:45pm-1:00pm | Genetic Predictors of Visual Dysfunction in People with Multiple Sclerosis Kathryn Fitzgerald, Johns Hopkins University |
| 1:00pm-1:20pm | Imaging Correlates of Axonal Damage in MS Susie Huang, Massachusetts General Hospital, Harvard Medical School |
| 1:20pm-1:35pm | VISIONARY-MS: A Phase 2 clinical trial of catalytic gold nanocrystals, CNM-Au8, for the treatment of chronic optic neuropathy Robert Glanzman, Clene Nanomedicine, Inc. |
| 1:35pm-1:45pm | Functional Connectivity Predicts MS Patients' Impairment Using An Ensemble Model Applied With A Machine Learning Approach Ceren Tozlu, Weill Cornell Medicine |
Please save the date for the following IMSVISUAL Events, taking place in conjunction with the ACTRIMS Forum 2020 in West Palm Beach, February 27-29, 2020.
Thursday, September 12, 2019, 17:00
Meeting Room B9, Stockholmsmässan
ECTRIMS Congress Venue
| 17:00 | Welcome and Proceedings F. Paul, Berlin |
| 17:15 | Results of the OCTIMS study F. Paul, Berlin |
| 17:30 | OCT in experimental MS models P. Albrecht, Düsseldorf |
| 17:45 | Vision investigator race 4 brief presentations by junior researchers TBD |
| 18:45 | Miscellaneous and Farewell |
| 19:00 | End |
Snacks and beverages will be provided.
The number of participants is limited to 50 pax. Please RSVP until September 5th, 2019, by using the online registration form.
It is our pleasure to invite you to our IMSVISUAL symposium at ACTRIMS Forum 2019 (being held in Dallas, Texas, February 28 – March 2), to discuss updates on vision research in multiple sclerosis and related disorders. For the third consecutive year we are fortunate to have secured ACTRIMS as our sponsor.
The symposium, integrated into the ACTRIMS program and CME accredited, will take place on Thursday, February 28th from 12:30pm – 1:45pm. Please see below the confirmed agenda for talks/speakers during the session. This symposium/session is open to all attendees of the ACTRIMS Forum 2019.
I think this will be an exciting symposium with presentations from
several groups representing existing IMSVISUAL member sites from
around the world.
We look forward to seeing you all in Dallas!
Session Chairs: Laura Balcer, NYU Langone Health and Elena Martínez-Laspiscina, Hospital Clínic de Barcelona
1: “Is there progressive retinal damage in neuromyelitis optica spectrum disorders?”
Friedemann Paul, NeuroCure Clinical Research Center
2: “Smartphone Suite of Visual Tests in Multiple Sclerosis”
Randy Kardon, University of Iowa Health Care
3: “Corneal Confocal Microscopy: “A rapid non-invasive technique to image neurodegeneration”
Ioannis Petropoulos, Weill Cornell Medicine – Qatar
4: “Dynamics of retinal layer atrophy in normal aging and multiple sclerosis”
Elias Sotirchos, Johns Hopkins University
5: “Retinal imaging in EAE for translational neuroprotection studies”
Philipp Albrecht, Heinrich-Heine-Universität Düsseldorf